P700: TREATMENT-FREE REMISSION (TFR) AFTER DASATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND DEEP MOLECULAR RESPONSE (DMR): FINAL 5-YEAR RESULTS OF DASFREE - N. P. Shah; V. García-Gutiérrez; A. Jiménez-Velasco; S. Saussele; D. Rea; F.-X. Mahon; M. Y. Levy; M. T. Gómez-Casares; M. J. Mauro; O. Sy; P. Martin-Regueira; J. H. Lipton (HemaSphere, 2022)